Total Payments
$1,089
2024 Payments
$106.16
Companies
8
Transactions
42
Medicare Patients
1,369
Medicare Billing
$78,084
Payment Breakdown by Category
Food & Beverage$980.77 (90.0%)
Education$108.47 (10.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $980.77 | 40 | 90.0% |
| Education | $108.47 | 2 | 10.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ViiV Healthcare Company | $474.83 | 19 | $0 (2024) |
| Gilead Sciences, Inc. | $229.03 | 10 | $0 (2024) |
| Janssen Biotech, Inc. | $149.83 | 5 | $0 (2021) |
| Dexcom, Inc. | $89.14 | 4 | $0 (2023) |
| Janssen Products, LP | $79.99 | 1 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $28.48 | 1 | $0 (2021) |
| Merck Sharp & Dohme LLC | $19.81 | 1 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $18.13 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $106.16 | 5 | ViiV Healthcare Company ($72.51) |
| 2023 | $364.95 | 16 | ViiV Healthcare Company ($245.35) |
| 2022 | $251.60 | 8 | Janssen Products, LP ($79.99) |
| 2021 | $366.53 | 13 | Janssen Biotech, Inc. ($149.83) |
All Payment Transactions
42 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/21/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $13.84 | General |
| 07/25/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/13/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: HIV | ||||||
| 02/06/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: HIV | ||||||
| 01/19/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $32.19 | General |
| Category: HIV | ||||||
| 12/28/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: Endocrinology | ||||||
| 12/28/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Endocrinology | ||||||
| 12/13/2023 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $28.88 | General |
| Category: HIV | ||||||
| 11/30/2023 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: HIV | ||||||
| 10/30/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.61 | General |
| 09/29/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.41 | General |
| 09/22/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $27.57 | General |
| Category: Endocrinology | ||||||
| 07/06/2023 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $26.51 | General |
| Category: HIV | ||||||
| 06/29/2023 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $1.54 | General |
| Category: HIV | ||||||
| 06/28/2023 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $31.77 | General |
| Category: HIV | ||||||
| 06/16/2023 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: HIV | ||||||
| 05/25/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.83 | General |
| 05/12/2023 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $30.80 | General |
| Category: HIV | ||||||
| 05/03/2023 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $25.31 | General |
| Category: HIV | ||||||
| 02/09/2023 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $31.53 | General |
| Category: HIV | ||||||
| 01/04/2023 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: HIV | ||||||
| 11/10/2022 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $26.66 | General |
| Category: HIV | ||||||
| 10/27/2022 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: Endocrinology | ||||||
| 05/12/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.05 | General |
| 04/07/2022 | Janssen Scientific Affairs, LLC | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Infectious Diseases & Vaccines | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 809 | 1,303 | $384,220 | $36,356 |
| 2022 | 4 | 255 | 504 | $223,991 | $18,703 |
| 2021 | 3 | 144 | 252 | $116,588 | $16,795 |
| 2020 | 4 | 161 | 220 | $103,540 | $6,231 |
Total Patients
1,369
Total Services
2,279
Medicare Billing
$78,084
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 76 | 125 | $22,500 | $8,315 | 37.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 77 | 134 | $191,084 | $7,785 | 4.1% |
| 87536 | Detection test by nucleic acid for hiv-1 virus, quantification | Office | 2023 | 22 | 62 | $28,830 | $5,171 | 17.9% |
| 77067 | Screening mammography | Office | 2023 | 14 | 14 | $2,800 | $2,061 | 73.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 98 | 209 | $5,225 | $1,756 | 33.6% |
| 88187 | Flow cytometry technique for dna or cell analysis, 2 to 8 markers | Office | 2023 | 22 | 62 | $44,578 | $1,584 | 3.6% |
| 86480 | Tuberculosis test, gamma interferon | Office | 2023 | 23 | 25 | $8,475 | $1,519 | 17.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 84 | 161 | $6,923 | $1,225 | 17.7% |
| 80076 | Liver function blood test panel | Office | 2023 | 78 | 141 | $25,380 | $1,129 | 4.5% |
| 87522 | Detection test by nucleic acid for hepatitis c virus, quantification | Office | 2023 | 23 | 26 | $6,318 | $1,091 | 17.3% |
| 87491 | Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique | Office | 2023 | 18 | 24 | $4,872 | $825.36 | 16.9% |
| 87591 | Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique | Office | 2023 | 17 | 20 | $4,100 | $687.80 | 16.8% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 39 | 52 | $4,680 | $682.24 | 14.6% |
| 82274 | Stool analysis for blood, by fecal hemoglobin determination by immunoassay | Office | 2023 | 40 | 41 | $3,567 | $639.60 | 17.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 43 | 58 | $3,480 | $552.16 | 15.9% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 16 | 21 | $2,310 | $310.38 | 13.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 26 | 29 | $10,330 | $300.15 | 2.9% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 12 | 14 | $1,400 | $276.57 | 19.8% |
| 86780 | Analysis for antibody, treponema pallidum | Office | 2023 | 13 | 14 | $3,612 | $181.71 | 5.0% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 26 | 29 | $1,740 | $90.19 | 5.2% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 14 | 14 | $1,078 | $79.24 | 7.4% |
| 82540 | Creatine measurement | Office | 2023 | 14 | 14 | $448.00 | $63.70 | 14.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 14 | 14 | $490.00 | $30.80 | 6.3% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 79 | 151 | $27,180 | $9,534 | 35.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 75 | 134 | $191,084 | $8,455 | 4.4% |
About Dr. Linda Croad, MD
Dr. Linda Croad, MD is a Infectious Disease healthcare provider based in Panorama City, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1548331457.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Linda Croad, MD has received a total of $1,089 in payments from pharmaceutical and medical device companies, with $106.16 received in 2024. These payments were reported across 42 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($980.77).
As a Medicare-enrolled provider, Croad has provided services to 1,369 Medicare beneficiaries, totaling 2,279 services with total Medicare billing of $78,084. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Panorama City, CA
- Active Since 11/13/2006
- Last Updated 12/02/2021
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1548331457
Products in Payments
- DOVATO (Drug) $254.03
- SYMTUZA (Drug) $247.95
- CABENUVA (Biological) $190.00
- Dexcom G6 Transmitter (Medical Supply) $89.14
- RUKOBIA (Drug) $30.80
- PIFELTRO (Drug) $19.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.